All Stories

  1. The Role of the Renin–Angiotensin–Aldosterone System in Hypertensive Emergencies
  2. Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure
  3. Comparison of Oscillometric Blood Pressure Measurements on the Arm and Forearm in Patients with Obesity, Prediabetes, and Hypertension
  4. New Insights on the ideal blood pressure levels for renal protection
  5. Correlations Between Coffee Intake, Glycemic Control, Cardiovascular Risk, and Sleep in Type 2 Diabetes and Hypertension: A 12-Month Observational Study
  6. A new approach to interpreting the LF/HF ratio: a study in hypertensive patients
  7. Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension
  8. Increased arterial stiffness in normotensive individuals with hypoparathyroidism
  9. The correlation between age, blood pressure variability and estimated pulse wave velocity
  10. The effect of breakfast skipping and sleep disorders on glycemic control, cardiovascular risk, and weight loss in type 2 diabetes
  11. A COVID-19 E A PRESSÃO NO AMBIENTE DE TRABALHO ENFRENTADA POR PROFISSIONAIS DE SAÚDE NO CONTEXTO HOSPITALAR
  12. The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity
  13. Demystifying Obesity: Understanding, Prevention, Treatment, and Stigmas
  14. Nutritional management, skipping breakfast, glycemic control, and cardiovascular risk on type 2 diabetes mellitus
  15. The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes
  16. AGE AND BLOOD PRESSURE DEPENDENCY OF THREE DIFFERENT METHODS TO MEASURE PULSE WAVE VELOCITY
  17. EFFECT OF SEQUENTIAL NEPHRON BLOCKADE X DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE + BISOPROLOL IN THE TREATMENT OF RESISTANT HYPERTENSION, A RANDOMIZED CONTROLLED TRIAL (RESHYPOT)
  18. Correlation between estimated pulse wave velocity values from two equations in healthy and under cardiovascular risk populations
  19. Effects of Mindful Eating in Patients with Obesity and Binge Eating Disorder
  20. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  21. Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
  22. Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review
  23. Evaluation of Central Hemodynamics in the Diagnosis and Treatment of Hypertension
  24. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  25. Abstract P378: Expression Of Micro-rna 221, 222 And 223 In Individuals Suffering From Ischemic Stroke Due To Hypertensive Emergency
  26. EXPRESSION OF MICRO-RNA 221 AND 223 IN ISCHEMIC STROKE DUE HYPERTENSIVE EMERGENCY
  27. ARTERIAL STIFFNESS IN NORMOTENSIVE PATIENTS WITH HYPOPARATHYROIDISM COMPARED TO CONTROLS
  28. SEQUENTIAL NEPHRON BLOCKADE VERSUS DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN TRUE RESISTANT HYPERTENSIVE PATIENTS: A SYSTEMATIC REVIEW
  29. EVALUATION OF DEPENDENCE OF AGE AND PERIPHERAL BLOOD PRESSURE IN TWO PULSE WAVE VELOCITY ESTIMATION METHODS
  30. The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
  31. The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes
  32. Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
  33. Editorial: The importance of the central hemodynamic in the cardiovascular diseases development
  34. Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis
  35. Linear and non-linear analyses of autonomic modulation in uncontrolled and controlled elderly resistant hypertensives
  36. Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus
  37. Smoking and Endothelial Dysfunction: An Integrated - Medical and Molecular Review
  38. CRISES HIPERTENSIVAS: MITOS, VERDADES E CONDUTAS
  39. HIPERTENSÃO E DIABETES: CONCEITOS ATUAIS NA TERAPÊUTICA
  40. Abstract P147: Association Between Lipid Transfer To HDL-c And Arterial Stiffness In Patients With Ischemic Stroke Due To Hypertensive Emergency
  41. Predictive Factors for Target Organ Injuries in Hypertensive Individuals
  42. RELATIONSHIP BETWEEN 24-HOURS URINARY SODIUM EXCRETION AND ARTERIAL STIFFNESS IN CONTROLLED HYPERTENSIVE AND RESISTANT HYPERTENSIVE INDIVIDUALS
  43. Diretrizes Brasileiras de Hipertensão Arterial – 2020
  44. Correction to: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
  45. Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
  46. Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers
  47. QUAL O PAPEL DO BLOQUEIO SEQUENCIAL DO NÉFRON NA HIPERTENSÃO RESISTENTE?
  48. Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática Clínica em Pacientes de Alto Risco Cardiovascular (REACT)
  49. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
  50. Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
  51. Abstract P081: Expression Of Micro-rnas And Transfer Of Lipids To HDL In Vitro In Stroke Due To Hypertensive Emergency
  52. May Measurement Month 2018: an analysis of blood pressure screening results from Brazil
  53. Posicionamento Luso-Brasileiro de Emergências Hipertensivas – 2020
  54. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
  55. Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
  56. Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil
  57. Central Hemodynamic Parameters are Altered in Resistant Hypertensive Individuals
  58. CRISES HIPERTENSIVAS: DEFININDO A GRAVIDADE E O TRATAMENTO
  59. Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial
  60. CIRCULATING LEVELS OF MATRIX METALLOPROTEINASE-9 ARE ELEVATED IN INDIVIDUALS WITH HYPERTENSIVE CRISIS
  61. INFLUENCE OF ANTIHYPERTENSIVE TREATMENT ON MMP-9 LEVELS IN CONTROLLED HYPERTENSIVE INDIVIDUALS
  62. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension
  63. Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?
  64. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized cont...
  65. Prevalence of Physical Inactivity and its Effects on Blood Pressure and Metabolic Parameters in a Brazilian Urban Population
  66. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
  67. Guidelines on the management of arterial hypertension and related comorbidities in Latin America
  68. Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis
  69. Vascular Peripheric Differences In Patients With Chagas Versus Ischemic Heart Failure
  70. I Luso-Brazilian Positioning on Central Arterial Pressure
  71. Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial
  72. Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin
  73. [PP.21.02] INDIVIDUALS WITH HYPERTENSIVE EMERGENCY PRESENT ASSOCIATION BETWEEN RENAL DYSFUNCTION AND INFLAMMATORY CYTOKINES
  74. [PP.36.12] METABOLIC CHANGES, BIOMARKERS OF ENDOTHELIAL DYSFUNCTION AND COAGULATION FACTORS ARE PRESENT IN INDIVIDUALS WITH HYPERTENSIVE CRISIS
  75. Endothelial Changes in Individuals with Prehypertension
  76. How to Investigate the Vascular Changes in Resistant Hypertension
  77. Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
  78. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension
  79. Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial
  80. Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
  81. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study
  82. Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension
  83. DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient
  84. PP.28.15
  85. PP.20.30
  86. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
  87. Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects
  88. Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?
  89. Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population
  90. Is There an Association between Periodontitis and Hypertension?
  91. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
  92. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  93. Renin Angiotensin System Blockage Associates with Insertion/Deletion Polymorphism of Angiotensin-Converting Enzyme in Patients with Hypertensive Emergency
  94. Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study
  95. Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure
  96. I posicionamento brasileiro sobre hipertensão arterial resistente
  97. Urinary albumin excretion regression in hypertensive individuals
  98. Hyperglycemia in patients with hypertensive crisis: Response to “Hypertensive crisis: Comparison between diabetics and non-diabetics”
  99. Fatores associados ao aumento no índice de incremento de pressão radial em indivíduos hipertensos
  100. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes
  101. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension
  102. Is There An Association Between Vitamin D and Hypertension?
  103. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial
  104. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial
  105. Hypertensive crisis: clinical–epidemiological profile
  106. Factors associated with impaired urinary albumin excretion in hypertensive individuals
  107. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness
  108. Metabolic Abnormalities Are Associated with Blood Pressure Control.
  109. UNCONTROLLED AND CONTROLLED RESISTANT HYPERTENSION: REALLY ONLY ONE HYPERTENSIVE CONDITION?: PP.34.412
  110. Prevalência e fatores de risco para hipertensão em uma população urbana brasileira
  111. ARTERIAL AND VENOUS ENDOTHELIAL DYSFUNCTION IN RESISTANT HYPERTENSIVE PATIENTS
  112. Coronary emergency and diabetes as manifestations of pheochromocytoma
  113. Ausência de descenso noturno se associa a acidente vascular cerebral e infarto do miocárdio
  114. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study
  115. H 027 Multifactorial Evaluation of the Interaction of Polymorphisms of Raas Genes and Nitric Oxide Endothelial Synthase in Resistant and Controlled Hypertensive Patients
  116. H 025 Concentric left Ventricular Hypertrophy as an Early Marker of Cardiovascular Risk in Resistant Hypertension
  117. H 005 Hypertensive Crisis: Clinical and Epidemiological Profile
  118. H 004 Nondipper is Associated with Stroke and Myocardial Infarction
  119. H 008 Predictors of In-hospital Mortality in Patients Admitted to Hospital Emergency Presenting Hypertensive Crisis
  120. H 015 Simultaneous Evaluation of Endothelial Function and Velocity of Wave Pulse in Resistant Hypertensive Patients
  121. Factors associated to patients' noncompliance with hypertension treatment
  122. Dissecção aguda de aorta como apresentação de emergência hipertensiva
  123. Prevalência e fatores sociodemográficos em hipertensos de São José do Rio Preto - SP
  124. Disfunção cognitiva após cirurgia cardíaca
  125. H 023 α-ADDUCIN GENETIC VARIANTS AND RISK FACTORS IN SYSTEMIC HYPERTENSION
  126. H 031 THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS SUFFERING FROM HYPERTENSIVE CRISES
  127. H 024 POLYMORPHISMS OF THE ACE INSERTION/DELETION, M235T ANGIOTENSINOGEN AND ENOS GLU298ASP GENES IN REFRACTORY HYPERTENSION
  128. H 025 EVALUATION OF ENDOTHELIAL FUNCTION AND VASCULAR THICKNESS IN REFRACTORY HYPERTENSIVE PATIENTS
  129. H 026 CARDIOVASCULAR REMODELING (CONCENTRIC LEFT VENTRICLE HYPERTROPHY AND INCREASE IN THE INTIMA-MEDIA THICKNESS) IN REFRACTORY HYPERTENSION
  130. H 029 ACE GENETIC POLYMORPHISMS IN PATIENTS SUFFERING HYPERTENSIVE CRISES
  131. H 036 CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH REFRACTORY ARTERIAL HYPERTENSION
  132. Alike the metabolic syndrome, hypertension is more than just increased blood pressure
  133. Infarto agudo do miocárdio e dissecção aguda de aorta: um importante diagnóstico diferencial
  134. Perfil de crise hipertensiva: prevalência e apresentação clínica
  135. Adenoma de Conn: uma causa de hipertensão e hipocalemia
  136. Introduction and basic concepts